Skip to content

BioLife Solutions, Inc.: 10-Q filed 2012-11-13

What BioLife Solutions, Inc. reported in its quarterly report filed 2012-11-13 (fiscal Q3 2012): 33 published measures, 86 facts as tagged in accession 0001354488-12-005749.

This filing

Form
10-Q (quarterly report)
Filed
2012-11-13
Fiscal period
fiscal Q3 2012
Accession
0001354488-12-005749 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BioLife Solutions, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2012-09-303,417,833USD
At 2011-12-311,662,017USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2012-09-3015,453,615USD
At 2011-12-3112,842,503USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2012-09-30-12,035,782USD
At 2011-12-31-11,180,486USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2012-09-307,529USD
At 2011-12-3116,864USD
At 2011-09-3020,117USD
At 2010-12-313,211USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-352,228USD92
2012-01-01 to 2012-09-30-1,147,998USD274
2011-07-01 to 2011-09-30-478,668USD92
2011-01-01 to 2011-09-30-1,545,469USD273

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2012-01-01 to 2012-09-30686,128USD274
2011-01-01 to 2011-09-30-797,122USD273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2012-01-01 to 2012-09-301,171,863USD274
2011-01-01 to 2011-09-3057,372USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2012-01-01 to 2012-09-30475,000USD274
2011-01-01 to 2011-09-30870,000USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-1,170,463USD274
2011-01-01 to 2011-09-30-55,972USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2012-09-30-55,299,489USD
At 2011-12-31-54,151,491USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2012-09-301,414,215USD
At 2011-12-31353,402USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2012-07-01 to 2012-09-3057,134USD92
2012-01-01 to 2012-09-30154,747USD274
2011-07-01 to 2011-09-3051,788USD92
2011-01-01 to 2011-09-30183,657USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-148,708USD92
2012-01-01 to 2012-09-30-634,602USD274
2011-07-01 to 2011-09-30-284,808USD92
2011-01-01 to 2011-09-30-999,097USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2012-09-301,777,597USD
At 2011-12-311,160,407USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2012-07-01 to 2012-09-30185,554USD92
2012-01-01 to 2012-09-30547,875USD274
2011-07-01 to 2011-09-30171,677USD92
2011-01-01 to 2011-09-30497,458USD273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2012-09-301,468,094USD
At 2011-12-31579,248USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2012-09-301,064,283USD
At 2011-12-31403,103USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2012-09-30797,943USD
At 2011-12-31547,143USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2012-07-01 to 2012-09-30744,157USD92
2012-01-01 to 2012-09-302,175,463USD274
2011-07-01 to 2011-09-30654,770USD92
2011-01-01 to 2011-09-301,945,191USD273

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2012-09-30849,211USD
At 2011-12-31505,956USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2012-07-01 to 2012-09-30595,449USD92
2012-01-01 to 2012-09-301,540,861USD274
2011-07-01 to 2011-09-30369,962USD92
2011-01-01 to 2011-09-30946,094USD273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2012-07-01 to 2012-09-30110,689USD92
2012-01-01 to 2012-09-30353,837USD274
2011-07-01 to 2011-09-3098,903USD92
2011-01-01 to 2011-09-30391,086USD273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2012-09-3069,679,854shares
At 2011-12-3169,679,854shares

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2012-09-301,969,674USD
At 2011-12-31800,795USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2012-09-30555,459USD
At 2011-12-31447,393USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2012-09-30149,609USD
At 2011-12-3169,582USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2012-09-30122,914USD
At 2011-12-3190,444USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2012-07-01 to 2012-09-30487,733USD92
2012-01-01 to 2012-09-301,441,852USD274
2011-07-01 to 2011-09-30500,424USD92
2011-01-01 to 2011-09-301,356,222USD273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2012-01-01 to 2012-09-30110,018USD274
2011-01-01 to 2011-09-3070,773USD273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2012-07-01 to 2012-09-30-203,520USD92
2012-01-01 to 2012-09-30-513,396USD274
2011-07-01 to 2011-09-30-193,860USD92
2011-01-01 to 2011-09-30-546,372USD273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-250,800USD274
2011-01-01 to 2011-09-30-119,778USD273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-30-343,255USD274
2011-01-01 to 2011-09-30-64,640USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2012-01-01 to 2012-09-30661,180USD274
2011-01-01 to 2011-09-30193,374USD273

Inspect the source

Entity
BioLife Solutions, Inc. / CIK 0000834365
Captured
2026-09-19T15:08:45.571Z
SEC response SHA-256
cc2cf8f92622e29fea17afa7805fcf370f2d2caa2d36b6cf780e7beb9e287e2f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000834365.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))